Assured Investment Management’s Ligand Pharmaceuticals LGND Stock Holding History

Assured Investment Management’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-56,568	Closed	-$4.44M	–	476
2019 Q1	$4.44M	Sell	56,568 -20,121	-26%	-$1.52M	0.05%	167
2018 Q4	$6.49M	Buy	76,689 +62,443	+438%	+$6.66M	0.18%	133
2018 Q3	$2.44M	Sell	14,246 -14,021	-50%	-$2.11M	0.04%	393
2018 Q2	$3.65M	Buy	28,267 +23,043	+441%	+$2.57M	0.07%	304
2018 Q1	$538K	Buy	+5,224	New	+$517K	0.01%	747
2017 Q2	–	Sell	-4,400	Closed	-$291K	–	665
2017 Q1	$291K	Buy	+4,400	New	+$289K	0.01%	495

Other funds holding LGND

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

CCMLC

Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Assured Investment Management's LGND Position: Q2 2019 in Review

Assured Investment Management sold out of Ligand Pharmaceuticals (LGND) in Q2 2019, closing a stake of 56,568 shares — an estimated $4.44M sold.

Assured Investment Management first reported a position in LGND in Q1 2017 and held it in 6 quarters. The position peaked at $6.49M in Q4 2018. 305 funds tracked by Wall St. Rank hold LGND as of Q2 2019.

Assured Investment Management reported no remaining Ligand Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
Assured Investment Management sold 56,568 Ligand Pharmaceuticals shares in Q2 2019, an estimated $4.44M.
Assured Investment Management first reported a position in Ligand Pharmaceuticals in Q1 2017 and held it in 6 quarters.
Assured Investment Management's Ligand Pharmaceuticals position peaked at $6.49M in Q4 2018.
305 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2019.

Based on Assured Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.